Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Fri, 24 Mar 17 12:01:21 +0000 Fri, 24 Mar 17 12:01:21 +0000 FDA Grants Accelerated Approval to First Treatment for Rare Skin Cancer http://www.pharmacytimes.com/product-news/fda-grants-accelerated-approval-to-first-treatment-for-rare-skin-cancer http://www.pharmacytimes.com/product-news/fda-grants-accelerated-approval-to-first-treatment-for-rare-skin-cancer The FDA granted accelerated approval to the first treatment for metastatic Merkel cell carcinoma (MCC).&nbsp; Thu, 23 Mar 17 19:33:53 +0000 How Does Social Media Impact Pharmacy Practice? http://www.pharmacytimes.com/news/how-does-social-media-impact-pharmacy-practice http://www.pharmacytimes.com/news/how-does-social-media-impact-pharmacy-practice Everybody seems to use social media, and pharmacists are no exception. However, it&#39;s been unclear how pharmacists employ social media in their daily professional practice. Thu, 23 Mar 17 14:59:53 +0000 Verdict Reached for NECC Pharmacist in Meningitis Outbreak Trial http://www.pharmacytimes.com/news/verdict-reached-for-necc-pharmacist-in-meningitis-outbreak-trial http://www.pharmacytimes.com/news/verdict-reached-for-necc-pharmacist-in-meningitis-outbreak-trial The meningitis outbreak trial&nbsp;involving the New England Compounding Center&nbsp;(NECC) pharmacist Barry Cadden has reached a final verdict.&nbsp; Wed, 22 Mar 17 16:03:20 +0000 Breast Cancer Drug Combo Improved Progression-Free Survival in Phase 3 Study http://www.pharmacytimes.com/product-news/breast-cancer-drug-combo-improved-progressionfree-survival-in-phase-3-study http://www.pharmacytimes.com/product-news/breast-cancer-drug-combo-improved-progressionfree-survival-in-phase-3-study Eli Lilly and Company recently announced positive late-stage results in its clinical trial testing a combination of its experimental breast cancer drug and another widely-used treatment.&nbsp; Wed, 22 Mar 17 13:52:20 +0000 FDA Approves Add-On Drug for Parkinson's Disease http://www.pharmacytimes.com/product-news/fda-approves-addon-drug-for-parkinsons-disease http://www.pharmacytimes.com/product-news/fda-approves-addon-drug-for-parkinsons-disease The FDA has approved Newron Pharmaceutical&rsquo;s Xadago (safinamide), an add-on treatment for patients with Parkinson&rsquo;s disease.&nbsp; Tue, 21 Mar 17 20:31:56 +0000 American Diabetes Association Alert Day Coming Up http://www.pharmacytimes.com/news/american-diabetes-association-alert-day-coming-up http://www.pharmacytimes.com/news/american-diabetes-association-alert-day-coming-up An estimated 86 million Americans have prediabetes, and 90% of them don&#39;t know they have it. Tue, 21 Mar 17 15:17:57 +0000 Health Groups Call for FDA to Ban All Flavored Tobacco Products http://www.pharmacytimes.com/news/health-groups-call-for-fda-to-ban-all-flavored-tobacco-products http://www.pharmacytimes.com/news/health-groups-call-for-fda-to-ban-all-flavored-tobacco-products &nbsp;<br /> Several public health and antismoking groups are urging the FDA to enforce more stringent regulations on the manufacturing of tobacco products&nbsp;by banning candy and fruit-flavored e-cigarettes and cigars.&nbsp; Tue, 21 Mar 17 14:55:09 +0000 ASCO Issues Global HPV Vaccination Guidelines for Cervical Cancer Prevention http://www.pharmacytimes.com/news/asco-issues-global-hpv-vaccination-guidelines-for-cervical-cancer-prevention http://www.pharmacytimes.com/news/asco-issues-global-hpv-vaccination-guidelines-for-cervical-cancer-prevention The American Society of Clinical Oncology (ASCO) released a clinical practice guideline on human papillomavirus (HPV) vaccination for the primary prevention of cervical cancer.&nbsp; Mon, 20 Mar 17 14:34:15 +0000 CDC: Long-Acting Opioids, Tramadol Most Likely to be Chronically Used http://www.pharmacytimes.com/news/cdc-longacting-opioids-tramadol-most-likely-to-be-chronically-used http://www.pharmacytimes.com/news/cdc-longacting-opioids-tramadol-most-likely-to-be-chronically-used Patients who take long-acting opioids are more likely to experience chronic opioid use, a report published in the CDC&rsquo;s <em>Morbidity and Mortality Weekly Report</em> has determined.&nbsp; Fri, 17 Mar 17 17:39:34 +0000 White Coats on Instagram: What Does Pharmacy Look Like? http://www.pharmacytimes.com/news/white-coats-on-instagram-what-does-pharmacy-look-like http://www.pharmacytimes.com/news/white-coats-on-instagram-what-does-pharmacy-look-like A new study published in the <em>Journal of the American Pharmacists Association</em> analyzed the use of the &ldquo;#pharmacist&rdquo; tag on Instagram.&nbsp; Fri, 17 Mar 17 14:26:01 +0000 Pharmacy Times and Parata Systems Host the 2017 Next-Generation Pharmacist Awards Gala http://www.pharmacytimes.com/news/pharmacy-times-and-parata-systems-host-the-2017-nextgeneration-pharmacist-awards-gala http://www.pharmacytimes.com/news/pharmacy-times-and-parata-systems-host-the-2017-nextgeneration-pharmacist-awards-gala <em>Award Finalists and Attendees to Enjoy Entertainment by Craig Karges at the San Diego Zoo</em> Thu, 16 Mar 17 14:05:02 +0000 Ebola Vaccines Yield Persistent Protection in Year-Long Trial http://www.pharmacytimes.com/product-news/ebola-vaccines-yield-persistent-protection-in-yearlong-trial http://www.pharmacytimes.com/product-news/ebola-vaccines-yield-persistent-protection-in-yearlong-trial &nbsp;<br /> An investigational Ebola vaccine showed promising results in an early-stage study, in which an induced immune response persisted in adult participants for nearly 1 year after receiving the vaccination. Thu, 16 Mar 17 11:00:00 +0000 FDA Issues Safety Warning for IBS Drug http://www.pharmacytimes.com/product-news/fda-issues-safety-warning-for-ibs-drug http://www.pharmacytimes.com/product-news/fda-issues-safety-warning-for-ibs-drug The FDA has issued a warning regarding the drug Viberzi (eluxadoline), which is used to treat irritable bowel syndrome with diarrhea (IBS-D).&nbsp; Thu, 16 Mar 17 00:00:00 +0000 Talking to Senior Patients about NSAIDs: Change Is Likely http://www.pharmacytimes.com/news/talking-to-senior-patients-about-nsaids-change-is-likely http://www.pharmacytimes.com/news/talking-to-senior-patients-about-nsaids-change-is-likely NSAIDs are included in the Beers criteria list as potentially inappropriate for older patients.&nbsp; Wed, 15 Mar 17 17:22:47 +0000 FDA Approves Keytruda for Treatment of Hodgkin Lymphoma http://www.pharmacytimes.com/product-news/fda-approves-keytruda-for-treatment-of-hodgkin-lymphoma http://www.pharmacytimes.com/product-news/fda-approves-keytruda-for-treatment-of-hodgkin-lymphoma Merck has announced the FDA&rsquo;s approval of Keytruda&rsquo;s indication for treatment in classical Hodgkin lymphoma (cHL) patients.&nbsp; Wed, 15 Mar 17 14:21:18 +0000 Three Dietary Supplement Manufacturers Ordered to Halt Operations http://www.pharmacytimes.com/news/three-dietary-supplement-manufacturers-ordered-to-halt-operations http://www.pharmacytimes.com/news/three-dietary-supplement-manufacturers-ordered-to-halt-operations Officials with the FDA noted that in past inspections, dating back as far as 2012, they have noticed the&nbsp;dietary supplement products were misbranded because they were being marketed with drug claims despite not being approved for any use. Tue, 14 Mar 17 18:50:22 +0000 FDA Approves First-Line Combo Treatment for HR+/HER2- Metastatic Breast Cancer http://www.pharmacytimes.com/product-news/fda-approves-firstline-combo-treatment-for-hrher2-metastatic-breast-cancer http://www.pharmacytimes.com/product-news/fda-approves-firstline-combo-treatment-for-hrher2-metastatic-breast-cancer &nbsp;<br /> The FDA has approved Novartis&rsquo; Kisqali (ribociclib), in combination with an aromatase inhibitor as initial endocrine-based therapy treatment, for the treatment of breast cancer.&nbsp; Tue, 14 Mar 17 12:00:00 +0000 Senate Confirms Seema Verma as CMS Administrator http://www.pharmacytimes.com/news/senate-green-lights-seema-verma-as-cms-administrator http://www.pharmacytimes.com/news/senate-green-lights-seema-verma-as-cms-administrator Several health care organizations applauded the pick.&nbsp; Mon, 13 Mar 17 23:38:53 +0000 Study: Parental Concerns Influence Flu Vaccine Uptake in Children http://www.pharmacytimes.com/news/study-parental-concerns-influence-flu-vaccine-uptake-in-children http://www.pharmacytimes.com/news/study-parental-concerns-influence-flu-vaccine-uptake-in-children A recent study investigated parental attitudes toward their child receiving a flu vaccine and its negative influence on vaccination rates.&nbsp; Mon, 13 Mar 17 12:00:00 +0000 President Expected to Pick Scott Gottlieb to Head FDA http://www.pharmacytimes.com/news/president-expected-to-pick-scott-gottlieb-to-head-fda http://www.pharmacytimes.com/news/president-expected-to-pick-scott-gottlieb-to-head-fda Dr Gottlieb,&nbsp;who has written in various newspapers and other media about the need to expedite drug approvals, falls in line&nbsp;with President Trump&rsquo;s criticism of the current FDA regulatory process.&nbsp; Sat, 11 Mar 17 13:34:32 +0000 Medical Organizations Raise Concerns About ACA Replacement Bill http://www.pharmacytimes.com/news/medical-organizations-raise-concerns-about-aca-replacement-bill http://www.pharmacytimes.com/news/medical-organizations-raise-concerns-about-aca-replacement-bill Leaders of several prominent medical organizations have voiced their opposition to the proposed bill aimed at replacing the Affordable Care Act. Fri, 10 Mar 17 22:19:24 +0000 Schizophrenia Medication Seeks Label Update for Maintenance Treatment http://www.pharmacytimes.com/product-news/schizophrenia-medication-seeks-label-update-for-maintenance-treatment http://www.pharmacytimes.com/product-news/schizophrenia-medication-seeks-label-update-for-maintenance-treatment The FDA has accepted Allergan&rsquo;s supplemental new drug application (sNDA) for Vraylar (cariprazine).&nbsp;<br /> &nbsp; Thu, 09 Mar 17 12:00:00 +0000 Pharmacists, Pharmacy Managers Rank on Glassdoor's Best-Paying Jobs List http://www.pharmacytimes.com/news/pharmacists-pharmacy-managers-rank-on-glassdoors-bestpaying-jobs-list http://www.pharmacytimes.com/news/pharmacists-pharmacy-managers-rank-on-glassdoors-bestpaying-jobs-list Glassdoor released its third annual list of the highest-paying professions in the United States, and both pharmacists and pharmacy managers landed among the top 25 jobs highlighted.&nbsp; Wed, 08 Mar 17 18:07:52 +0000 Survey: Safer Acetaminophen Use and Increased Risk Awareness Among Americans http://www.pharmacytimes.com/news/survey-safer-acetaminophen-use-and-increased-risk-awareness-among-americans http://www.pharmacytimes.com/news/survey-safer-acetaminophen-use-and-increased-risk-awareness-among-americans In a nationwide survey conducted by the Consumer Healthcare Products Association Educational Foundation, a larger portion of acetaminophen users in the United States reported knowing how to use the drug safely and effectively while avoiding potential risks.&nbsp; Tue, 07 Mar 17 18:05:53 +0000 An Overview of the Proposed ACA Replacement Plan http://www.pharmacytimes.com/news/everything-you-need-to-know-about-the-proposed-affordable-care-act-replacement-plan http://www.pharmacytimes.com/news/everything-you-need-to-know-about-the-proposed-affordable-care-act-replacement-plan Some aspects of the ACA will remain, others are on the chopping block.&nbsp; Tue, 07 Mar 17 18:00:21 +0000